These findings suggest that IGF1 may influence GABAergic neural development, potentially contributing to the symptomatic derangements observed in human neurological disorders, particularly neurodevelopmental disorders such as ASD and attention‐deficit/hyperactivity disorder (ADHD). The gene discussed is IGF1; the disease is nervous system disorder.